Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus

BACKGROUND To cope with the emergence of multidrug-resistant tuberculosis (MDR-TB), new molecular methods that can routinely be used to screen for a wide range of drug resistance related genetic markers in the Mycobacterium tuberculosis genome are urgently needed. OBJECTIVE To evaluate the perfor...

Full description

Bibliographic Details
Main Authors: Paula Fernanda Gonçalves dos Santos, Elis Regina Dalla Costa, Daniela M Ramalho, Maria Lucia Rossetti, Regina Bones Barcellos, Luciana de Souza Nunes, Leonardo Souza Esteves, Rodrigo Rodenbusch, Richard M Anthony, Indra Bergval, Sarah Sengstake, Miguel Viveiros, Afrânio Kritski, Martha M Oliveira
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ)
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017000600396&lng=en&tlng=en
_version_ 1797715795619348480
author Paula Fernanda Gonçalves dos Santos
Elis Regina Dalla Costa
Daniela M Ramalho
Maria Lucia Rossetti
Regina Bones Barcellos
Luciana de Souza Nunes
Leonardo Souza Esteves
Rodrigo Rodenbusch
Richard M Anthony
Indra Bergval
Sarah Sengstake
Miguel Viveiros
Afrânio Kritski
Martha M Oliveira
author_facet Paula Fernanda Gonçalves dos Santos
Elis Regina Dalla Costa
Daniela M Ramalho
Maria Lucia Rossetti
Regina Bones Barcellos
Luciana de Souza Nunes
Leonardo Souza Esteves
Rodrigo Rodenbusch
Richard M Anthony
Indra Bergval
Sarah Sengstake
Miguel Viveiros
Afrânio Kritski
Martha M Oliveira
author_sort Paula Fernanda Gonçalves dos Santos
collection DOAJ
description BACKGROUND To cope with the emergence of multidrug-resistant tuberculosis (MDR-TB), new molecular methods that can routinely be used to screen for a wide range of drug resistance related genetic markers in the Mycobacterium tuberculosis genome are urgently needed. OBJECTIVE To evaluate the performance of multiplex ligaton-dependent probe amplification (MLPA) against Genotype® MTBDRplus to detect resistance to isoniazid (INHr) and rifampicin (RIFr). METHOD 96 culture isolates characterised for identification, drug susceptibility testing (DST) and sequencing of rpoB, katG, and inhA genes were evaluated by the MLPA and Genotype®MTBDRplus assays. RESULTS With sequencing as a reference standard, sensitivity (SE) to detect INHr was 92.8% and 85.7%, and specificity (SP) was 100% and 97.5%, for MLPA and Genotype®MTBDRplus, respectively. In relation to RIFr, SE was 87.5% and 100%, and SP was 100% and 98.8%, respectively. Kappa value was identical between Genotype®MTBDRplus and MLPA compared with the standard DST and sequencing for detection of INHr [0.83 (0.75-0.91)] and RIFr [0.93 (0.88-0.98)]. CONCLUSION Compared to Genotype®MTBDRplus, MLPA showed similar sensitivity to detect INH and RIF resistance. The results obtained by the MLPA and Genotype®MTBDRplus assays indicate that both molecular tests can be used for the rapid detection of drug-resistant TB with high accuracy. MLPA has the added value of providing information on the circulating M. tuberculosis lineages.
first_indexed 2024-03-12T08:12:02Z
format Article
id doaj.art-86356cccc5134c48a540e1f17a46aa10
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T08:12:02Z
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-86356cccc5134c48a540e1f17a46aa102023-09-02T19:06:43ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-8060112639640310.1590/0074-02760160376S0074-02762017000600396Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplusPaula Fernanda Gonçalves dos SantosElis Regina Dalla CostaDaniela M RamalhoMaria Lucia RossettiRegina Bones BarcellosLuciana de Souza NunesLeonardo Souza EstevesRodrigo RodenbuschRichard M AnthonyIndra BergvalSarah SengstakeMiguel ViveirosAfrânio KritskiMartha M OliveiraBACKGROUND To cope with the emergence of multidrug-resistant tuberculosis (MDR-TB), new molecular methods that can routinely be used to screen for a wide range of drug resistance related genetic markers in the Mycobacterium tuberculosis genome are urgently needed. OBJECTIVE To evaluate the performance of multiplex ligaton-dependent probe amplification (MLPA) against Genotype® MTBDRplus to detect resistance to isoniazid (INHr) and rifampicin (RIFr). METHOD 96 culture isolates characterised for identification, drug susceptibility testing (DST) and sequencing of rpoB, katG, and inhA genes were evaluated by the MLPA and Genotype®MTBDRplus assays. RESULTS With sequencing as a reference standard, sensitivity (SE) to detect INHr was 92.8% and 85.7%, and specificity (SP) was 100% and 97.5%, for MLPA and Genotype®MTBDRplus, respectively. In relation to RIFr, SE was 87.5% and 100%, and SP was 100% and 98.8%, respectively. Kappa value was identical between Genotype®MTBDRplus and MLPA compared with the standard DST and sequencing for detection of INHr [0.83 (0.75-0.91)] and RIFr [0.93 (0.88-0.98)]. CONCLUSION Compared to Genotype®MTBDRplus, MLPA showed similar sensitivity to detect INH and RIF resistance. The results obtained by the MLPA and Genotype®MTBDRplus assays indicate that both molecular tests can be used for the rapid detection of drug-resistant TB with high accuracy. MLPA has the added value of providing information on the circulating M. tuberculosis lineages.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017000600396&lng=en&tlng=entuberculosisMLPAGenoTypeMTBDR®plusisoniazid resistancerifampicin resistancemultidrug resistance
spellingShingle Paula Fernanda Gonçalves dos Santos
Elis Regina Dalla Costa
Daniela M Ramalho
Maria Lucia Rossetti
Regina Bones Barcellos
Luciana de Souza Nunes
Leonardo Souza Esteves
Rodrigo Rodenbusch
Richard M Anthony
Indra Bergval
Sarah Sengstake
Miguel Viveiros
Afrânio Kritski
Martha M Oliveira
Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
Memorias do Instituto Oswaldo Cruz
tuberculosis
MLPA
GenoTypeMTBDR®plus
isoniazid resistance
rifampicin resistance
multidrug resistance
title Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
title_full Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
title_fullStr Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
title_full_unstemmed Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
title_short Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus
title_sort detection of tuberculosis drug resistance a comparison by mycobacterium tuberculosis mlpa assay versus genotype r mtbdrplus
topic tuberculosis
MLPA
GenoTypeMTBDR®plus
isoniazid resistance
rifampicin resistance
multidrug resistance
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017000600396&lng=en&tlng=en
work_keys_str_mv AT paulafernandagoncalvesdossantos detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT elisreginadallacosta detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT danielamramalho detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT marialuciarossetti detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT reginabonesbarcellos detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT lucianadesouzanunes detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT leonardosouzaesteves detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT rodrigorodenbusch detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT richardmanthony detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT indrabergval detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT sarahsengstake detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT miguelviveiros detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT afraniokritski detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus
AT marthamoliveira detectionoftuberculosisdrugresistanceacomparisonbymycobacteriumtuberculosismlpaassayversusgenotypemtbdrplus